Safety and immunogenicity of Onderstepoort Biological Products’ Rift Valley fever Clone 13 vaccine in sheep and goats under field conditions in Senegal

Modou M. Lo; Victor Mbao; Pascale Sierra; Yaya Thiongane; Mariame Diop; Meritxell Donadeu; Baptiste Dungu

Crossref Citations

1. An Overview of Rift Valley Fever Vaccine Development Strategies
Paul Kato Kitandwe, Paul F. McKay, Pontiano Kaleebu, Robin J. Shattock
Vaccines vol: 10 issue: 11 first page: 1794 year: 2022
doi: 10.3390/vaccines10111794

African Online Scientific Information Systems (Pty) Ltd t/a AOSIS
Reg No: 2002/002017/07
International Tel: +27 21 975 2602
5 Hafele Street, Durbanville, Cape Town, 7550, South Africa
publishing(AT)aosis.co.za replace (AT) with @

All articles published in this journal are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license, unless otherwise stated.
Website design & content: ©2024 AOSIS (Pty) Ltd. All rights reserved. No unauthorised duplication allowed.
By continuing to use this website, you agree to our Privacy Policy, Terms of Use and Security Policy.

________

Subscribe to our newsletter

Get specific, domain-collection newsletters detailing the latest CPD courses, scholarly research and call-for-papers in your field.

Onderstepoort Journal of Veterinary Research | ISSN: 0030-2465 (PRINT) | ISSN: 2219-0635 (ONLINE)